These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 387109)

  • 41. [Effect of estrogens on the development of the leukocyte migration inhibition reaction in vitro in malignant neoplasms].
    Alferov AN; Grinevich IuA
    Probl Endokrinol (Mosk); 1979; 25(4):31-4. PubMed ID: 314113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
    Crivii SM; Crişan M; Crişan M
    Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukocyte migration inhibition in vitro in untreated and methimazole-treated patients with Graves disease.
    Kálmán K; Fazakas S; Erdei I; Leövey A
    Acta Med Acad Sci Hung; 1976; 33(4):327-32. PubMed ID: 1037636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Leukocyte migration studies in gastric cancer detection: an approach toward improved specificity and sensitivity.
    Zöller M; Matzku S; Schulz U
    J Natl Cancer Inst; 1977 Apr; 58(4):897-904. PubMed ID: 845993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro transfer of immunity against PPD with dialyzable extract of leukocytes from human colostrum].
    Martínez-Cairo Cueto S; Alasio-Chávez C; Dávila Velázquez JR
    Rev Alerg; 1992; 39(6):126-32. PubMed ID: 1492196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical immunological characteristics of the cellular reaction of tumor stroma in stomach cancer].
    Kliachkin BM
    Sov Med; 1979 Aug; (8):31-4. PubMed ID: 515824
    [No Abstract]   [Full Text] [Related]  

  • 51. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
    Polack FM; Habash N; Zam ZS; Burdette MG
    Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Leukocyte adhesion suppression reaction for determining the immunological reactivity of oncological patients].
    Frolova LM; Govallo VI
    Vopr Onkol; 1978; 24(5):10-4. PubMed ID: 351953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of tumor associated antigens in squamous cell carcinoma.
    Krause CJ
    Laryngoscope; 1979 Jul; 89(7 Pt 1):1105-20. PubMed ID: 87996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.
    Nakajima T; Chikamori M; Isojima K; Iwaguchi T
    Gan; 1977 Aug; 68(4):449-57. PubMed ID: 80343
    [No Abstract]   [Full Text] [Related]  

  • 55. Leucocyte migration inhibition by tumour-associated antigens in human bladder carcinoma.
    Meleady DF; Butler MR; Greally JF; Mullins GM
    Ir J Med Sci; 1980 Oct; 149(10):391-400. PubMed ID: 7014519
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunologic capacity of tumour patients. I. Leukocyte migration inhibition with ppD in patients at different tumour stages].
    Makidono R; Murakami J; Jingu K; Kitagawa S; Matsuura K; Makidono A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Feb; 45(2):403-6. PubMed ID: 4011416
    [No Abstract]   [Full Text] [Related]  

  • 57. Reactivity of gastric cancer patients in leucocyte migration inhibition tests to 3M KCl extracts from gastric tumor.
    Kojima O; Oh A; Kitagawa N; Uehara Y; Nishioka B; Fujita Y; Majima S
    Jpn J Surg; 1981; 11(6):413-21. PubMed ID: 7035728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunoassessment of patients with gastric cancer. Using leukocyte migration inhibition (LMI) test.
    Kojima O; Uehara Y; Majima T; Ikeda E; Nishioka B; Fujita Y; Majima S
    Gastroenterol Jpn; 1983 Aug; 18(4):303-9. PubMed ID: 6628918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of leucocyte migration by potassium chloride extracts of human tumor cells in ascites and from tissues.
    Imai K; Hosokawa Y; Abe H; Yachi A; Wada T
    Gan; 1977 Oct; 68(5):581-7. PubMed ID: 73489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence that human leukocyte inhibitory factor (LIF) is an esterase.
    Rocklin RE; Rosenthal AS
    J Immunol; 1977 Jul; 119(1):249-52. PubMed ID: 326958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.